http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20120021249-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2cc6e3d88e27a0ec7a61dff186e5279 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1824 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1887 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 |
filingDate | 2011-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a918ce2671083695525663399ded2bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbf03239d68458f3e0ddd0fb1a772a80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4e29f1d482377a3c687cdfdc5e2e74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16f74422f091b669dae34662b0861248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b473dc26acacdd2437868ef4dc98d38f |
publicationDate | 2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20120021249-A |
titleOfInvention | Preparation method of iron oxide nanocapsules, iron oxide nanocapsules and MRI contrast agents using the same |
abstract | The present invention relates to an iron oxide nanocapsule for MRI contrast agent with excellent contrast and a method for producing the same. Iron oxide nanocapsules encapsulated in a capsule material comprising, there is a characteristic that satisfies the following relations 1, 2, 3, 4 and 5. (Relationship 1) 5 ≤ 100 * D m (IO) / C v (IO) (Relationship 2) 2.5 ≤ 100 * D m (Cap) / C v (Cap) (Relationship 3) 0.5 wt% ≤ F (IO) ≤ 50 wt% (Relationship 4) 1nm ≤ D m (IO) ≤ 25nm (Relationship 5) 50nm ≤ D m (Cap) ≤ 200nm (D m (IO) in the relation 1 is the average size of the iron oxide nanoparticles, C v (IO) is the standard deviation in the size distribution of the iron oxide nanoparticles, in the equation 2 D m (Cap) is iron oxide nanocapsules Is the average size of, C v (Cap) is the standard deviation in the size distribution of the iron oxide nanocapsules, F (IO) in the equation 3 is the weight percent of the iron oxide nanoparticles encapsulated in the iron oxide nanocapsules, D in the equation 4 m (IO) is the same as the definition of relation 1, D m (Cap) in the relation 5 is the same as the definition of relation 2. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102026100-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020197046-A1 |
priorityDate | 2010-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 80.